Q1 2025 Earnings Summary
- Accelerating Management Fee Growth: With NC4 set to activate in Q2 2025 and a pipeline of $64 billion in committed but uncalled capital, fee revenues are expected to accelerate, supporting long-term earnings growth.
- Rapid Expansion in Asset-Based Finance: The asset-backed finance segment is growing at an estimated 35–40% year-over-year with increased deployment activity, which bolsters fee income from private credit initiatives.
- Resilient Insurance Segment with Upside Potential: Despite current operating earnings around $250 million, initiatives to extend annuity durations and increase alternative exposure are paving the way for a target all-in ROE of 20%+ and substantial future revenue from capital markets fees.
- Delayed fee revenue activation: Despite expectations for management fee acceleration, a significant portion of KKR’s capital remains uncalled and hinges on timely deployment (e.g., NC4 activation in Q2). Any delay in converting this $64 billion of dry powder into fee-earning assets could postpone revenue growth, which is a potential headwind.
- Rising distribution and expense pressures: As KKR expands its capital markets and distribution channels—targeting several hundred million dollars in future fees—the associated costs (such as placement fees and expanded distribution expenses) may compress fee-related earnings (FRE) margins. This headwind is highlighted by management’s focus on balancing growth investments with margin preservation, even as FRE margins have hovered at the high 60% level.
- Macro uncertainty and market volatility risks: The persistent market volatility and geopolitical uncertainties (including potential second- or third-order impacts from tariffs and broader economic shocks) could adversely affect deal flow, monetization activities, and capital-raising efforts across asset classes. This uncertain environment may delay strategic initiatives and weigh on future performance.
| Metric | YoY Change | Reason |
|---|---|---|
Total Revenue | -67.8% | Total revenue in Q1 2025 fell from $9,656.738 million to $3,110.183 million, primarily because the dramatic drop in high insurance revenue from the prior period was not sustained this period. The high insurance revenue in Q1 2024, which significantly boosted total revenue, did not recur, offsetting modestly higher asset management revenue vs. |
Asset Management | +4.7% | Asset Management revenue increased modestly from $1,956.468 million to $2,045.915 million, reflecting steady organic growth driven by increased transaction and management fees that built on the previous period’s performance without the extraordinary volatility seen in insurance revenue vs. |
Insurance | -86.2% | Insurance revenue plummeted from $7,700.270 million to $1,064.268 million, largely because Q1 2024 benefited from a one‐off large block reinsurance transaction and related premium recognition. In Q1 2025, the absence of such a transaction combined with external market and reinsurance factors led to a sharp decline in net premiums and associated fees vs. |
| Metric | Period | Previous Guidance | Current Guidance | Change |
|---|---|---|---|---|
Insurance Operating Earnings | Q2 2025 | "Expected to remain plus or minus the Q4 2024 level" | "Expected to stay around $250 million plus or minus" | no change |
Management Fees | Q2 2025 | no prior guidance | "Anticipated acceleration in management fee growth from the 14% growth seen in 2024. $64 billion of AUM not yet turned on fees, with a weighted average management fee of roughly 100 basis points. The Americas fund (NC4) is expected to be activated in Q2 2025." | no prior guidance |
Overall Business Strategy | Q2 2025 | no prior guidance | "Aim to achieve a sustainable 20-plus percent all-in ROE for the insurance business, with significant asset management economics alongside." | no prior guidance |
FRE Margin | Q2 2025 | no prior guidance | "Belief in operating sustainably at a mid-60% FRE margin, with recent quarters close to the high 60% level. No cap on this margin, expected to expand as the business scales." | no prior guidance |
Fundraising and Financial Metrics | Q2 2025 | no prior guidance | "Confidence in achieving the 2026 guidance shared previously, across both fundraising and financial metrics." | no prior guidance |
| Topic | Previous Mentions | Current Period | Trend |
|---|---|---|---|
Accelerating Management Fee Growth & NC4 Activation | In Q2 2024, management fee growth was supported by new fund activations although NC4’s timing was uncertain and delay risk was highlighted. Q3 2024 and Q4 2024 emphasized robust fee growth without detailed discussion of NC4 delay risk. | Q1 2025 stressed accelerating fee growth with clear visibility—NC4 is confirmed to activate in Q2 2025, reducing delay risk. | More positive and decisive outlook; concerns over delay risk have been resolved. |
Rapid Expansion in Asset-Based Finance & Private Credit Fee Income | Q2 through Q4 2024 showed strong growth in ABF and private credit fee income, with robust AUM expansion in both segments and increasing deployment activity. | Q1 2025 continued to report significant growth with ABF AUM growing 35%–40% year-over-year and private credit fee income driven by attractive market conditions. | Consistently bullish with upward growth and sustained momentum. |
Fundraising Momentum & New Strategy Execution | Q2–Q4 2024 featured vigorous discussions on multi-billion-dollar capital raises, diversified strategies (including climate and strategic holdings), and new product launches. | In Q1 2025, while fundraising remained strong (with a $31 billion raise and a $14 billion first close), there was less emphasis on new strategy execution compared to earlier quarters. | Continued momentum in fundraising but a relative de‑emphasis on new strategy execution details. |
Capital Markets Pipeline & Monetization Opportunities vs Revenue Sustainability | Previous quarters (Q2–Q4 2024) discussed robust capital markets revenue, increasing monetization activity, and high FRE margins with strong long‑term visibility. | Q1 2025 maintained optimism with solid Q1 capital markets revenue ($230 million) and clear monetization pipeline, alongside long‑term revenue sustainability leveraged by uncalled capital. | Steady and optimistic outlook with consistent themes of strong pipeline and resilient revenue drivers. |
Infrastructure Business Growth & AUM Expansion | Q2–Q4 2024 reported significant AUM growth (from $15B to $73B in Q2 and notable organic expansion in Q3–Q4), with strong geographic diversification and strategic fundraising for infrastructure funds. | Q1 2025 highlighted continued growth with a 4% quarterly and 13% annual appreciation, plus international diversification in Europe and Asia reinforcing the positive trend. | Persistent and bullish, with consistent global expansion and robust performance. |
Insurance Segment Transformation & Global Atlantic ROE Evolution | Q2–Q4 2024 set out a mixed narrative: strategic shifts with longer-dated liabilities and increased alternative exposure caused short‑term pressure on ROE while aiming for a long‑term target of 14–15%. | Q1 2025 reiterated the transformation, noting stable insurance operating earnings around $250 million and an all‑in ROE approaching 20%, acknowledging near‑term pressures but a clear long‑term benefit. | Mixed sentiment persists: short‑term P&L pressure remains but long‑term profitability is reinforced. |
Market Volatility, Macroeconomic Uncertainty & Geopolitical Risks Impacting Deal Flow | In Q2–Q4 2024, these themes were mentioned indirectly with improvements in market conditions and diversification mitigating risks, with Q4 noting resilience through diversified geographic exposure. | Q1 2025 addressed heightened volatility (since early April), active deployment despite uncertainty, and a robust global deal pipeline that leverages diversification to overcome geopolitical risks. | Amplified focus in current period; while uncertainty and volatility remain, KKR demonstrates proactive deployment and risk management. |
Rising Distribution, Expense & Margin Pressure Challenges on Fee Revenues | Q2 2024 and Q4 2024 acknowledged rising distribution and operating costs but noted that these investments had quantifiable ROI and were offset by operating leverage; Q3 2024 touched on fee-related costs indirectly. | Q1 2025 addressed increasing placement fees and distribution costs but emphasized maintained FRE margins in the mid‑60% range and clear ROI supporting accelerated fee growth. | Ongoing challenge that is viewed as an investment in growth, with a consistent message that rising costs are strategic rather than purely negative. |
Liquidity Deployment Challenges & Near-Term ROE Pressure from Uncalled Capital | Q2–Q3 2024 discussed elevated liquidity levels and temporary ROE pressure due to lagging deployment of large uncalled capital pools, with detailed analysis on deployment timing. | Q1 2025 reiterated the challenge with $116 billion of uncalled capital and $64 billion yet to earn fees, but stressed strong investment activity ($30B+ deployed) that positions the firm for future growth despite near‑term ROE pressures. | Consistent concern; near‑term pressures persist but are framed as necessary for long‑term strategic deployment. |
Emerging K-Series Investment Products & Secondary Market Expansion Opportunities | In Q2–Q4 2024, strong growth in K-Series products was emphasized (with AUM increases from $3B to $16B+) and there was notable discussion of secondary opportunities like corporate carve‑outs and sponsor‐to‐sponsor transactions. | Q1 2025 focused on emerging K-Series investment products in early stages of launch (including private equity and yield‑oriented strategies) while secondary market expansion was less emphasized than before. | K-Series products are increasingly important, though secondary market opportunities are receiving relatively less spotlight in the current period. |
Traditional Private Equity Portfolio Performance Stagnation (no longer emphasized) | In Q4 2024, there were comments on a flat quarter for traditional private equity—attributed to benchmarking challenges—but mixed with overall annual gains and confidence in long‑term performance. Q3 and Q2 2024 showcased positive performance metrics. | Q1 2025 did not mention any performance stagnation; the focus shifted to positive growth metrics and strong year‑to‑date performance. | The topic appears to have faded in emphasis as portfolio performance has improved, indicating a more positive sentiment. |
-
Mgmt Fee Growth
Q: Will management fees accelerate above current levels?
A: Management expects fees to accelerate from 14% growth as unactivated capital of $64 billion begins to generate fees (NC4 activating in Q2), with a robust pipeline driving future increases. -
Capital Returns
Q: What is the share buyback strategy?
A: Leaders stressed a consistent capital allocation approach, using share buybacks to enhance earnings per share—historically retiring shares near $28—to deliver long-term value. -
Fundraising Timeline
Q: When is the final close for flagship funds?
A: The team noted that while the Americas fund has already held its first close at $14 billion, final close dates remain unannounced, with Asia fundraisings set to follow a barbell strategy. -
Ins./Cap Markets
Q: What are insurance ROE targets and cap market plans?
A: Management highlighted a goal for an all-in ROE of 20%+ in insurance and plans to grow Capital Markets fees from $50 million to several hundred million over time, focusing on long-term integration. -
FRE Margin
Q: Can FRE margins expand beyond mid-60% levels?
A: They indicated that while FRE margins have hovered near the high 60%, disciplined expense management and scalable revenue should keep margins healthy despite market headwinds. -
Asset Finance
Q: How is asset-backed finance performing?
A: The asset-backed finance business is performing strongly, with ABF AUM at $74 billion and growing between 35%–40%, showcasing solid deployment in a competitive market. -
PE Performance
Q: Will PE performance drive industry consolidation?
A: Management expects increased dispersion in private equity returns, leading to capital concentrating with the best performers rather than a full market shakeout, thanks to disciplined, linear deployment. -
LP Sentiment
Q: How are institutional LP discussions amid volatility?
A: Engagement with LPs remains constructive, with clients staying liquid and cautiously optimistic, continually seeking opportunities amid uncertainty. -
Tariff Impact
Q: How will tariffs affect the portfolio?
A: They reassured that 90% of private equity AUM faces no first-order impact from tariffs, with built-in contractual protections and active mitigation minimizing overall exposure. -
Asia Business
Q: What is the impact of the trade war in Asia?
A: Despite trade tensions, management maintains that their diversified operations in Asia are well positioned to capitalize on intra-Asian opportunities, with no strategic change expected. -
Cap Markets Fees
Q: Are debt-focused fees a long-term focus?
A: Consistently, approximately 2/3 of transaction fees remain debt-focused, reflecting a stable, enduring strategy to support differentiated financing. -
Private Wealth
Q: Will private wealth flows accelerate post-correction?
A: While flows have been modest, management anticipates that as market conditions improve, private wealth adoption may accelerate owing to strong performance. -
Distribution Strategy
Q: What is the future for wealth distribution vehicles?
A: Early-stage initiatives include target date funds and model portfolios aimed at long-term performance, setting the foundation for broadening product offerings over time. -
Bank Debt
Q: How is bank debt availability evolving?
A: Despite tightening spreads, bank financing remains available, and the firm’s private credit options provide flexible alternatives for executing deals smoothly. -
Insurance Earnings
Q: Will insurance earnings exceed the $250M range soon?
A: For the near term, insurance operating earnings are expected to remain around $250 million, as ongoing portfolio repositioning and integration gradually enhance returns.